$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Metal oxide nanoparticles possess magnetic, electric, and catalytic properties, which have been applied in bioimaging1,2,3, sensor technologies4,5, catalysis6,7,8, energy storage9, and water purification10. Within the biomedical field, iron oxide nanoparticles and manganese oxide (MnO) nanoparticles have proven utility as contrast agents in magnetic resonance imaging (MRI)1,2. Iron oxide nanoparticles produce robust negative contrast on T2* MRI and are powerful enough to visualize single labeled cells in vivo11,12,13; however, the negative MRI signal cannot be modulated and remains “ON” throughout the duration of typical experiments. Due to endogenous iron present in the liver, bone marrow, blood and spleen, the negative contrast generated from iron oxide nanoparticles may be difficult to interpret. MnO nanoparticles, on the other hand, are responsive to a drop in pH. MRI signal for MnO nanoparticles can transition from “OFF” to “ON” once the nanoparticles are internalized inside the low pH endosomes and lysosomes of the target cell such as a cancer cell14,15,16,17,18,19. The positive contrast on T1 MRI produced from the dissolution of MnO to Mn2+ at low pH is unmistakable and can improve cancer detection specificity by only lighting up at the target site within a malignant tumor. Control over nanoparticle size, morphology and composition is crucial to achieve maximum MRI signal from MnO nanoparticles. Herein, we describe how to synthesize and characterize MnO nanoparticles using the thermal decomposition method and note different strategies for fine-tuning nanoparticle properties by altering variables in the synthesis process. This protocol can be easily modified to produce other magnetic nanoparticles such as iron oxide nanoparticles.
MnO nanoparticles have been produced by a variety of techniques including thermal decomposition20,21,22,23,24,25, hydro/solvothermal26,27,28,29, exfoliation30,31,32,33,34, permanganates reduction35,36,37,38, and adsorption-oxidation39,40,41,42. Thermal decomposition is the most commonly used technique which involves dissolving manganese precursors, organic solvents, and stabilizing agents at high temperatures (180 – 360 °C) under the presence of an inert gaseous atmosphere to form MnO nanoparticles43. Out of all of these techniques, thermal decomposition is the superior method to generate a variety of MnO nanocrystals of pure phase (MnO, Mn3O4 and Mn2O3) with a narrow size distribution. Its versatility is highlighted through the ability to tightly control nanoparticle size, morphology and composition by altering reaction time44,45,46, temperature44,47,48,49, types/ratios of reactants20,45,47,48,50 and inert gas47,48,50 used. The main limitations of this method are the requirement for high temperatures, the oxygen-free atmosphere, and the hydrophobic coating of the synthesized nanoparticles, which requires further modification with polymers, lipids or other ligands to increase solubility for biological applications14,51,52,53.
Besides thermal decomposition, the hydro/solvothermal method is the only other technique that can produce a variety of MnO phases including MnO, Mn3O4, and MnO2; all other strategies only form MnO2 products. During hydro/solvothermal synthesis, precursors such as Mn(II) stearate54,55 and Mn(II) acetate27 are heated to between 120-200 °C over several hours to achieve nanoparticles with a narrow size distribution; however, specialized reaction vessels are required and reactions are performed at high pressures. In contrast, the exfoliation strategy involves treatment of a layered or bulk material to promote dissociation into 2D single layers. Its main advantage is in producing MnO2 nanosheets, but the synthesis process is long requiring several days and the resulting size of the sheets is difficult to control. Alternatively, permanganates such as KMnO4 can react with reducing agents such as oleic acid56,57, graphene oxide58 or poly(allylamine hydrochloride)59 to create MnO2 nanoparticles. Use of KMnO4 facilitates nanoparticle formation at room temperature over a few minutes to hours within aqueous conditions43. Unfortunately, the rapid synthesis and nanoparticle growth makes it challenging to finely control resulting nanoparticle size. MnO2 nanoparticles can also be synthesized using adsorption-oxidation whereby Mn2+ ions are adsorbed and oxidized to MnO2 by oxygen under basic conditions. This method will produce small MnO2 nanoparticles with a narrow size distribution at room temperature over several hours in aqueous media; however the requirement for adsorption of Mn2+ ions and alkali conditions limits its widespread application43.
Of the MnO nanoparticle synthesis methods discussed, thermal decomposition is the most versatile to generate different monodisperse pure phase nanocrystals with control over nanoparticle size, shape and composition without requiring specialized synthesis vessels. In this manuscript, we describe how to synthesize MnO nanoparticles by thermal decomposition at 280 °C using manganese(II) acetylacetonate (Mn(II) ACAC) as the source of Mn2+ ions, oleylamine (OA) as the reducing agent and stabilizer, and dibenzyl ether (DE) as the solvent under a nitrogen atmosphere. The glassware and tubing setup for nanoparticle synthesis is explained in detail. One advantage of the technique is the inclusion of a temperature controller, thermocouple probe, and heating mantle to enable precise control over the heating rate, peak temperature, and reaction times at each temperature to fine-tune nanoparticle size and composition. Herein, we show how nanoparticle size can also be manipulated by changing the ratio of OA to DE. Additionally, we demonstrate how to prepare nanoparticle samples and measure nanoparticle size, bulk composition and surface composition using transmission electron microscopy (TEM), x-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FTIR), respectively. Further guidance is included on how to analyze the collected images and spectra from each instrument. To generate uniformly shaped MnO nanoparticles, a stabilizer and adequate nitrogen flow must be present; XRD and TEM results are shown for undesired products formed in the absence of OA and under low nitrogen flow. In the Discussion section, we highlight crucial steps in the protocol, metrics to determine successful nanoparticle synthesis, further variation of the decomposition protocol to modify nanoparticle properties (size, morphology and composition), troubleshooting and limitations of the method, and applications of MnO nanoparticles as contrast agents for biomedical imaging.